Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SHRA-2009 by Jiangsu Hengrui Medicine for Metastatic Breast Cancer: Likelihood of Approval
SHRA-2009 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Metastatic Breast Cancer. According to...